Results 291 to 299 of about 303,277 (299)
Some of the next articles are maybe not open access.

Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells

Immunopharmacology and Immunotoxicology, 2012
Takuya Miyawaki   +2 more
exaly  

Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6.

Cytokine, 2012
M. Shimizu   +6 more
semanticscholar   +1 more source

Interleukin–6 ( IL-6 ) rs1800796 and cyclin dependent kinase inhibitor ( CDKN2A/CDKN2B ) rs2383207 are associated with ischemic stroke in indigenous West African Men

Journal of the Neurological Sciences, 2017
Rufus Akinyemi   +2 more
exaly  

Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis

New England Journal of Medicine, 2015
Joachim Sieper   +2 more
exaly  

ACE inhibitors reduce post-CABG release of interleukin-6

Inpharma Weekly, 2002
openaire   +1 more source

Population Pharmacokinetic/ Pharmacodynamics of Interleukin-6 Receptor Inhibitor

Binyi Hu   +11 more
openaire   +1 more source

Oral and Maxillofacial Pathology: Interleukin‐1 β, interleukin‐6, and tissue inhibitor of metalloproteinase‐1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction

Oral Diseases, 2000
exaly  

POS0702 HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INTERLEUKIN-6 INHIBITORS AND JANUS KINASE INHIBITORS

Annals of the Rheumatic Diseases
E. Perea   +12 more
openaire   +1 more source

HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INTERLEUKIN-6 INHIBITORS AND JANUS KINASE INHIBITORS

Perea E   +12 more
openaire   +1 more source
interleukin-6
rheumatoid arthritis
olokizumab
il-6 inhibitor
tocilizumab
interleukin 6
inflammation
biologics
cytokines
previous   28  29  30  

Home - About - Disclaimer - Privacy